Matrix Asset Advisors Inc's Q4 2022 Portfolio Update: New Holdings and Increased Positions

Matrix Asset Advisors Inc, a New York-based investment management firm, recently filed its 13F form for Q4 2022, revealing a total portfolio value of $665 million, distributed among 88 stocks. The firm is led by David Katz and has a history of successful investments.

The top five positions in their portfolio include companies such as Microsoft Corp, valued at $38.4 million. Microsoft is a technology company that develops, licenses, and sells computer software, consumer electronics, and personal computers and services. It is one of the world's largest software makers by revenue.

Another top position in their portfolio is JPMorgan Chase & Co, valued at $29.4 million. JPMorgan Chase is a multinational investment bank and financial services company. It is the largest bank in the United States and one of the largest banks in the world.

Gilead Sciences, Inc. is another top holding, valued at $27.2 million. Gilead Sciences is a research-based biopharmaceutical company that discovers, develops, and commercializes innovative therapeutics in areas of unmet medical need.

CVS Health Corp, valued at $27.2 million, is also a top holding. CVS Health is an American healthcare company that owns CVS Pharmacy, a retail pharmacy chain, and CVS Caremark, a pharmacy benefits manager.

Finally, AbbVie Inc, valued at $25.6 million, rounds out the top five positions in Matrix Asset Advisors' portfolio. AbbVie is a research-based biopharmaceutical company that discovers, develops, and markets both biopharmaceuticals and small molecule drugs.

Looking at the 13F form, it's clear that Matrix Asset Advisors has seen an increase in the current position value, from $610 million to $665 million, with the majority of the growth coming from their top five holdings. The firm's focus on well-established companies in the technology, finance, and healthcare sectors, indicates a strategy of investing in stable and profitable companies.

One of the most notable moves made by the firm during this period was the acquisition of 30 new stocks.

Of these 30 new stocks, 7 were entirely new holdings for the firm, while the positions in 23 stocks were increased and positions in 43 stocks were reduced.

In this article, we'll take a closer look at the 5 new holdings that the firm has acquired in Q4 2022.

• Tyson Foods Inc (TSN) - The firm acquired 46.8K shares of TSN, making it one of their new holdings. Tyson Foods is one of the largest processors and marketers of chicken, beef, and pork in the world.
• TechnipFMC plc (TCHP) - The firm acquired 22.7K shares of TCHP, making it one of their new holdings. TechnipFMC is a leading provider of technology, engineering, and project management services for the oil and gas industry.
• Vanguard FTSE Emerging Markets ETF (VWO) - The firm acquired 26.5K shares of VWO, making it one of their new holdings. This ETF is designed to track the performance of the FTSE Emerging Markets All Cap China A Inclusion Index, which includes companies from emerging markets around the world, but with a focus on China.
• iShares Russell 1000 Value ETF (IWD) - The firm acquired 2.06K shares of IWD, making it one of their new holdings. This ETF is designed to track the performance of the Russell 1000 Value Index, which includes large and mid-cap U.S. companies that are considered to be undervalued by the market.
• Boeing Co (BA) - The firm acquired 1.61K shares of BA, making it one of their new holdings. Boeing is one of the world's largest aerospace companies, known for manufacturing commercial jetliners and military aircraft.

It is important to note that these new holdings only represent a small portion of the firm's overall portfolio, and should not be taken as a recommendation to buy.

Discover more information about Matrix Asset Advisors Inc's Q4 2022 portfolio and recent transactions here.